Irvine, March 19, 2015 – Renegade Racing, a premier running, triathlon & adventure sports production company in Southern California, is excited to partner with Celiac Disease Foundation’s Team Gluten-Free (TGF) for the XTERRA Renegade Off-Road Triathlon, Duathlon & 3 Mile Trail Run Challenge. TGF is a community fundraising program that provides a simple way for […]
Celiac Disease Foundation drives diagnosis and treatment of celiac disease through advocacy, education and advancing research to improve the quality of life for all people affected by gluten-related disorders
Celiac Disease Foundation is pleased to announce our participation in the Autoimmune Research Network, known as ARNet. ARNet is a network of autoimmune disease advocacy organizations that will foster research into celiac disease and related autoimmune conditions. In consonance with CDF’s Strategic Plan to increase national awareness of the ramifications of undiagnosed celiac disease, the first goal of […]
Women experience unique symptoms and side effects when dealing with celiac disease. Join CDF Registered Dietitian Nutritionist, Janelle Smith, and CDF Medical Advisory Board Member, Dr. Sheila Crowe, in our upcoming Ask-the-Dietitian Webinar on March 19 at 12:00pm PST.
On March 1 and 2, 2015, Talia Hassid, Celiac Disease Foundation’s Community Coordinator, attended the Digestive Disease National Coalition Public Policy Forum held in Washington DC. The forum gathers representatives from digestive disease organizations across the U.S. together to arrive at a common agenda to influence health care policy in the United States.
Underscoring its role as a leader in online tools for the gluten-free community, Celiac Disease Foundation (CDF) today launched the Gluten-Free Allergy-Free Marketplace, a new retail destination hosted on celiac.org. Featured at celiac.org/marketplace, the Marketplace showcases products and services from companies that care about the gluten-free and allergy-free community, and have made a deep commitment […]
Celiac Disease Foundation is pleased to announce the March 30-31, 2015, U.S. Food and Drug Administration (FDA) public workshop on Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT3). This scientific meeting will address endpoints and outcome measures for clinical trials for products intended to treat adult and/or pediatric celiac disease and inflammatory bowel disease.